3/11
04:15 pm
optn
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Low
Report
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
1/16
01:40 pm
optn
OptiNose, Inc. (NASDAQ: OPTN) had its price target lowered by analysts at Lake Street Capital from $45.00 to $17.00. They now have a "buy" rating on the stock.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) had its price target lowered by analysts at Lake Street Capital from $45.00 to $17.00. They now have a "buy" rating on the stock.
1/15
08:47 am
optn
Optinose reports preliminary Q4 2024 XHANCE revenue [Seeking Alpha]
High
Report
Optinose reports preliminary Q4 2024 XHANCE revenue [Seeking Alpha]
1/15
08:04 am
optn
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million [Yahoo! Finance]
Medium
Report
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million [Yahoo! Finance]
1/15
07:00 am
optn
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
High
Report
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
1/3
08:00 am
optn
OptiNose, Inc. (NASDAQ: OPTN) had its price target raised by analysts at HC Wainwright from $5.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
OptiNose, Inc. (NASDAQ: OPTN) had its price target raised by analysts at HC Wainwright from $5.00 to $18.00. They now have a "buy" rating on the stock.
12/26
07:12 am
optn
Optinose Announces 1-for-15 Reverse Stock Split [Yahoo! Finance]
High
Report
Optinose Announces 1-for-15 Reverse Stock Split [Yahoo! Finance]
12/26
07:00 am
optn
Optinose Announces 1-for-15 Reverse Stock Split
Medium
Report
Optinose Announces 1-for-15 Reverse Stock Split